NELSON研究:低剂量CT筛查中新发实性结节的肺癌风险特征
该研究基于NELSON随机对照试验的 incidence 筛查轮次,纳入1280个新发实性非钙化结节,其中73个(6%)为肺癌。多变量分析显示,在体积截断值基础上,右肺上叶位置、中心分布及回顾可见<15 mm3是肺癌的独立预测因素,但三分类风险分层改善有限。
要点
- 新发结节中肺癌比例为6%(73/1280)。
- 回顾可见<15 mm3且≥30 mm3的结节中22%(6/27)为肺癌。
- 右肺上叶、中心分布及回顾可见<15 mm3独立预测肺癌。
核心结论
- 在体积基础上,生长非依赖性特征(位置、分布、回顾可见性)可改善新发结节的肺癌预测,但三分类分层改善有限。
研究设计与样本
- 基于荷兰-比利时肺癌筛查(NELSON)随机对照试验的 incidence 筛查轮次,纳入新发或既往低于检测限(15 mm3)的实性非钙化结节,共1280个。
主要发现
- 1280个新发结节中73个(6%)为肺癌。
- ≥30 mm3且回顾可见<15 mm3的结节中22%(6/27)为肺癌。
- 基于体积截断值的AUC为0.80(95% CI 0.75–0.84),连续体积AUC为0.82(95% CI 0.77–0.87)。
- 调整体积截断值后,右肺上叶位置OR 2.0(P=0.012)、中心分布OR 2.4(P=0.001)、回顾可见<15 mm3 OR 4.7(P=0.003)为显著预测因素。
- 连续模型概率AUC为0.85(95% CI 0.81–0.89),三风险组分层AUC为0.82(95% CI 0.78–0.86)。
关键数值与推荐
- 体积截断值:<30 mm3、30–<200 mm3、≥200 mm3。
- 回顾可见<15 mm3的定义为既往检测限以下。
临床怎么用
- 对新发实性结节,除体积外应关注右肺上叶位置、中心分布及回顾可见<15 mm3等特征以辅助风险分层。
局限性
- 三分类风险分层下,生长非依赖性特征的附加价值有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: New nodules after baseline are regularly found in low-dose CT lung cancer screening and have a high lung cancer probability. It is unknown whether morphological and location characteristics can improve new nodule risk stratification by size. METHODS: Solid non-calcified nodules detected during incidence screening rounds of the randomised controlled Dutch-Belgian lung cancer screening (NELSON) trial and registered as new or previously below detection limit (15 mm3) were included. A multivariate logistic regression analysis with lung cancer as outcome was performed, including previously established volume cut-offs (<30 mm3, 30-<200 mm3 and ≥200 mm3) and nodule characteristics (location, distribution, shape, margin and visibility <15 mm3 in retrospect). RESULTS: Overall, 1280 new nodules were included with 73 (6%) being lung cancer. Of nodules ≥30 mm3 at detection and visible <15 mm3 in retrospect, 22% (6/27) were lung cancer. Discrimination based on volume cut-offs (area under the receiver operating characteristic curve (AUC): 0.80, 95% CI 0.75 to 0.84) and continuous volume (AUC: 0.82, 95% CI 0.77 to 0.87) was similar. After adjustment for volume cut-offs, only location in the right upper lobe (OR 2.0, P=0.012), central distribution (OR 2.4, P=0.001) and visibility <15 mm3 in retrospect (OR 4.7, P=0.003) remained significant predictors for lung cancer. The Hosmer-Lemeshow test (P=0.75) and assessment of bootstrap calibration curves indicated adequate model fit. Discrimination based on the continuous model probability (AUC: 0.85, 95% CI 0.81 to 0.89) was superior to volume cut-offs alone, but when stratified into three risk groups (AUC: 0.82, 95% CI 0.78 to 0.86), discrimination was similar. CONCLUSION: Contrary to morphological nodule characteristics, growth-independent characteristics may further improve volume-based new nodule lung cancer prediction, but in a three-category stratification approach, this is limited. TRIAL REGISTRATION NUMBER: ISRCTN63545820; pre-results.
引用
- Walter JE, Heuvelmans MA, Bock GH, et al. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study. Thorax. 2018. PMID: 29661918. doi:10.1136/thoraxjnl-2017-211376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。